1. INTRODUCTION
Cervical cancer is still one of the worst health threats to women worldwide, reported in Global Cancer Statistics 2020 [1]. Clinical pathology screening with liquid-based cytology (LBC, thinprep) is a positive recommendation for the early detection of cervical precancerous lesions and effectively prevents the progression of invasive cancer [2]. However, inefficient and labor-intensive conventional analysis under microscopy cannot meet the growing demand for regular screening. In recent years, the advancement of digital pathology technology has led to significant progress in clinical processing through the digitalization of whole slide images. With the evolution of deep neural networks (DNNs) such as convolutional neural networks (CNN) and vision transformers [3], [4], [5], artificial intelligence (AI)-assisted diagnosis can significantly strengthen the working efficiency and diagnostic quality of pathologists.